Zentalis Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $465k | 31k | 15.15 |
| 2023-09-30 | $616k | 31k | 20.06 |
| 2023-06-30 | $721k | 26k | 28.21 |
| 2023-03-31 | $429k | 25k | 17.20 |
| 2022-12-31 | $502k | 25k | 20.14 |
| 2022-09-30 | $540k | 25k | 21.66 |
| 2022-06-30 | $553k | 20k | 28.10 |
| 2022-03-31 | $907k | 20k | 46.12 |
| 2021-12-31 | $1.1M | 13k | 84.07 |
| 2021-09-30 | $835k | 13k | 66.64 |
| 2021-06-30 | $630k | 12k | 53.17 |
| 2021-03-31 | $514k | 12k | 43.38 |
| 2020-12-31 | $615k | 12k | 51.91 |
| 2020-09-30 | $166k | 5.1k | 32.70 |
| 2020-06-30 | $244k | 5.1k | 48.06 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors